Stay updated with breaking news from பால் பீட்டர் டக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEEDHAM, Mass. (BUSINESS WIRE) Candel Therapeutics, a clinical-stage biotechnology company, developing novel immune-based cancer therapeutics, today announced the appointment of Chris Matheny, PharmD, Ph.D., as vice president, development leader. Dr. Matheny will work closely with other members of the leadership team to continue efforts in building a clinical development organization that will deliver differentiated medicines with the potential to save, extend and improve the lives of cancer patients. “It is a distinct pleasure to have a highly strategic and accomplished drug developer like Chris join the Candel team. His passion for advancing therapeutics for oncology patients aligns perfectly with our steadfast goal of delivering effective oncolytic viral immunotherapies designed to improve survival, while also maintaining quality of life,” said Paul Peter Tak, M.D., Ph.D., president and CEO of Candel Therapeutics. “Chris ....
Candel Therapeutics Appoints Chris Matheny, PharmD, Ph.D., as Vice President, Development Leader apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.